The NABOTA Vision

Daewoong Pharmaceutical announced its vision for ‘NABOTA’ sweeping the global botulinum toxin market

- A large-scale press conference was held to announce domestic roll-out of NABOTA and global vision on April 16

- NABOTA has reached a milestone of KRW 700 billion in cumulative export sales, poised to hit the record high exports in domestic pharmaceutical industry

- CEO and other high-ranking officials of U.S.-based Evolus visited Korea and put forward blueprint for NABOTA making a clean sweep of U.S. and European market